-
Company Insights
Boehringer Ingelheim – Digital Transformation Strategies
Boehringer Digital Transformation Strategies Report Overview Boehringer Ingelheim (Boehringer) is tapping into key disruptive technologies including AI, big data, digital therapeutics, and cloud, among others to enhance its operational efficiency and product offerings. The annual ICT spending of Boehringer is estimated at $1.0 billion for 2022. A major share of this spending is earmarked for acquiring software, ICT services and hardware from vendors. Boehringer is a family-owned pharmaceutical company engaged in the discovery, development, manufacture, and marketing of human pharmaceuticals...